CVS Health (CVS)Sen. Alan Armstrong disclosed a purchase $1K–$15K

$1,001–$15,000

Reported range · official band, not an exact amount

116 days

Disclosure lag

Traded

Mar 27, 2026

Disclosed

Jul 21, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jan 23, 2025Insider · Bought outside the usual windowOfficer purchased ~$1.3K of CVS shares in the open market
2. Nov 21, 2025CongressDisclosed partial sale of CVS — reported range $1,001 - $15,000
3. Jan 29, 2026CongressDisclosed purchase of CVS — reported range $1,001 - $15,000
4. Feb 10, 2026Company filing · Form 8-K · ResultsReported its results
5. Mar 18, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 18, 2026, the Board of Directors (the “Board”) of CVS Health Corporation (“CVS Health” or the “Company”) elected John E. Gallina to serve on the Board, effective March 19, 2026.”
6. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
7. Mar 27, 2026 · this disclosureCongressDisclosed purchase of CVS — reported range $1,001 - $15,000

What came next

1. Mar 31, 2026Government · Federal Register proposed ruleFiduciary Duties in Selecting Designated Investment Alternatives
2. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
3. May 6, 2026Company filing · Form 8-K · ResultsReported its results
4. May 8, 2026Insider · 6 days before an 8-KOfficer sold ~$6.23M of CVS shares in the open market
5. May 14, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On May 14, 2026, CVS Health Corporation (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders approved the 2026 Incentive Compensation Plan of CVS Health Corporation (the “2026 ICP”), which replaces the Company’s expiring 2017 Incentive Compensation Plan.”
6. May 19, 2026Insider · 1 personInsiders: 2 sales (~$187.3M)
7. May 20, 2026Insider · 1 personInsiders: 4 sales (~$95.5M)
8. May 21, 2026Insider · 1 personInsiders: 2 sales (~$69.9M)

How to read Senate eFD periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for CVS Health

For CVS Health, OQRO holds 1 Congress trade report, 46 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CVS page.

Other recent filings by Sen. Alan Armstrong

• Senate eFD periodic transaction report at Williams Companies (WMB)Sep 17, 2026
• Senate eFD periodic transaction report at Williams Companies (WMB)Sep 17, 2026
• Senate eFD periodic transaction report at KKR & Co. (KKR)Jul 21, 2026
• Senate eFD periodic transaction report at Globe Life (GL)Jul 21, 2026
• Senate eFD periodic transaction report at Copart (CPRT)Jul 21, 2026

The full history of Sen. Alan Armstrong is on the profile page.

How this filing works

• The STOCK Act

Other disclosures at CVS Health

• USAspending.gov award recordSep 25, 2026
• USAspending.gov award recordAug 17, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its CVS page.